Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3-iodo-(131i)benzyl)guanidine
2. 123i Labeled 3-iodobenzylguanidine
3. 125i Labeled 3-iodobenzylguanidine
4. 3 Iodobenzylguanidine
5. 3 Iodobenzylguanidine, 123i Labeled
6. 3 Iodobenzylguanidine, 125i Labeled
7. 3-iodobenzylguanidine
8. 3-iodobenzylguanidine, 123i Labeled
9. 3-iodobenzylguanidine, 125i Labeled
10. Iobenguane
11. Iobenguane (131i)
12. M Iodobenzylguanidine
13. M-iodobenzylguanidine
14. Meta Iodobenzylguanidine
15. Meta-iodobenzylguanidine
16. Mibg
1. 87862-25-7
2. Mibg
3. Iobenguane Sulphate
4. M-iodobenzylguanidine Hemisulfate
5. M-iodobenzyl Guanidine Sulfate
6. 1-(3-iodobenzyl)guanidine Hemisulfate
7. Mibg (sulfate)
8. 3-iodobenzyl-guanidine Sulfate
9. M-iodobenzyl Guanidine Sulphate
10. 3-iodobenzyl-guanidine Sulphate
11. Iobenguane (sulfate)
12. Guanidine, N-((3-iodophenyl)methyl)-, Sulfate (2:1)
13. M-idobenzyl Guanidine Sulfate [vandf]
14. Guanidine, [(3-iodophenyl)methyl]-, Sulfate (2:1)
15. M-iodobenzylguanidine Hemisulfate Salt
16. Mibg Hemisulfate
17. Ncgc00094011-01
18. S8i0922465
19. Dsstox_cid_25773
20. Dsstox_rid_81115
21. Dsstox_gsid_45773
22. 3-iodobenzylguanidine Hemisulfate
23. Cas-87862-25-7
24. Ncgc00015572-04
25. Eu-0100644
26. 1-(3-iodobenzyl)guanidine Hcl
27. Chembl1374843
28. 3-iodobenzylguanidine Hemisulphate
29. 3-iodobenzyl-guanidine Hemisulfate
30. Hms3262a09
31. Unii-s8i0922465
32. Tox21_111237
33. Tox21_113518
34. Tox21_500644
35. 1-(3-iodobenzyl)guanidinehemisulfate
36. Akos015996512
37. Meta-iodobenzylguanidine Sulfate
38. Ccg-221948
39. Lp00644
40. Ncgc00261329-01
41. Bs-45793
42. E74924
43. I 9890
44. 2-[(3-iodophenyl)methyl]guanidine; Sulfuric Acid
45. A839961
46. 2-[(3-iodanylphenyl)methyl]guanidine; Sulfuric Acid
47. Q27289056
48. M-iodobenzylguanidine Hemisulfate Salt, >=98% (hplc And Tlc)
49. 3-iodobenzyl-guanidine Hemisulfate 103346-16-3 80663-96-3
50. Iobenguane Sulfate, European Pharmacopoeia (ep) Reference Standard
51. 80663-96-3
| Molecular Weight | 648.3 g/mol |
|---|---|
| Molecular Formula | C16H22I2N6O4S |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 647.95127 g/mol |
| Monoisotopic Mass | 647.95127 g/mol |
| Topological Polar Surface Area | 212 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 247 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Radiopharmaceuticals
Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21543
Submission : 2008-04-18
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
NDC Package Code : 71934-0026
Start Marketing Date : 2023-03-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100mg/100mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71934-0025
Start Marketing Date : 2023-03-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1000mg/1000mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71934-0027
Start Marketing Date : 2023-03-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5mg/5mg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Iobenguane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iobenguane, including repackagers and relabelers. The FDA regulates Iobenguane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iobenguane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Iobenguane supplier is an individual or a company that provides Iobenguane active pharmaceutical ingredient (API) or Iobenguane finished formulations upon request. The Iobenguane suppliers may include Iobenguane API manufacturers, exporters, distributors and traders.
click here to find a list of Iobenguane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Iobenguane DMF (Drug Master File) is a document detailing the whole manufacturing process of Iobenguane active pharmaceutical ingredient (API) in detail. Different forms of Iobenguane DMFs exist exist since differing nations have different regulations, such as Iobenguane USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Iobenguane DMF submitted to regulatory agencies in the US is known as a USDMF. Iobenguane USDMF includes data on Iobenguane's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Iobenguane USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Iobenguane suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Iobenguane as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Iobenguane API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Iobenguane as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Iobenguane and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Iobenguane NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Iobenguane suppliers with NDC on PharmaCompass.
Iobenguane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iobenguane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iobenguane GMP manufacturer or Iobenguane GMP API supplier for your needs.
A Iobenguane CoA (Certificate of Analysis) is a formal document that attests to Iobenguane's compliance with Iobenguane specifications and serves as a tool for batch-level quality control.
Iobenguane CoA mostly includes findings from lab analyses of a specific batch. For each Iobenguane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iobenguane may be tested according to a variety of international standards, such as European Pharmacopoeia (Iobenguane EP), Iobenguane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iobenguane USP).
LOOKING FOR A SUPPLIER?
